Target Name: LOC105376139
NCBI ID: G105376139
Review Report on LOC105376139 Target / Biomarker Content of Review Report on LOC105376139 Target / Biomarker
LOC105376139
Other Name(s): LOC105376139 variant X2 | LOC105376139 variant X1 | Uncharacterized LOC105376139, transcript variant X1 | Uncharacterized LOC105376139, transcript variant X2 | uncharacterized LOC105376139

LOC105376139 as a Drug Target for various Diseases

LOC105376139 (LOC105376139 variant X2) is a protein that is expressed in various tissues of the human body, including the brain, heart, and kidneys. It is a member of the heat shock protein (HSP) family, which are proteins that are involved in the regulation of protein synthesis and degradation in response to changes in cellular stress.

Recent studies have identified LOC105376139 (LOC105376139 variant X2) as a potential drug target for the treatment of various diseases, including neurodegenerative disorders, heart failure, and cancer. This is because LOC105376139 (LOC105376139 variant X2) is involved in the regulation of cellular stress responses, and targeting this protein may allow for the development of new therapeutic approaches for these diseases.

One of the key mechanisms by which LOC105376139 (LOC105376139 variant X2) is involved in cellular stress responses is its role in the regulation of protein synthesis and degradation. HSPs are involved in the transfer of thermal energy from the environment to proteins, which is critical for the regulation of protein function and stability. LOC105376139 (LOC105376139 variant X2) is involved in the regulation of protein synthesis and degradation by helping to maintain the stability of other HSPs.

In addition to its role in protein synthesis and degradation, LOC105376139 (LOC105376139 variant X2) is also involved in the regulation of cellular stress responses. HSPs are involved in the regulation of cellular stress responses by helping to prevent the formation of aggregates that can cause cell death. LOC105376139 (LOC105376139 variant X2) is involved in this process by helping to regulate the formation of aggregates of the protein involved in the stress response.

The identification of LOC105376139 (LOC105376139 variant X2) as a potential drug target has implications for the treatment of various diseases. For example, LOC105376139 (LOC105376139 variant X2) has been shown to be involved in the regulation of neurodegenerative disorders, such as Alzheimer's disease. By targeting LOC105376139 (LOC105376139 variant X2), researchers may be able to develop new therapeutic approaches for the treatment of these disorders.

In addition to its potential role in the treatment of neurodegenerative disorders, LOC105376139 (LOC105376139 variant X2) has also been shown to be involved in the regulation of heart failure and cancer. By targeting this protein, researchers may be able to develop new therapeutic approaches for the treatment of heart failure and cancer.

Overall, LOC105376139 (LOC105376139 variant X2) is a protein that is involved in the regulation of cellular stress responses in the body. Its potential as a drug target makes it an attractive target for the development of new therapeutic approaches for a variety of diseases. Further research is needed to fully understand the role of LOC105376139 (LOC105376139 variant X2) in cellular stress responses and its potential as a drug target.

Protein Name: Uncharacterized LOC105376139

The "LOC105376139 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105376139 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105376156 | LOC105376157 | LOC105376158 | LOC105376161 | LOC105376169 | LOC105376171 | LOC105376177 | LOC105376187 | LOC105376193 | LOC105376196 | LOC105376205 | LOC105376206 | LOC105376208 | LOC105376211 | LOC105376214 | LOC105376219 | LOC105376223 | LOC105376225 | LOC105376234 | LOC105376244 | LOC105376247 | LOC105376250 | LOC105376253 | LOC105376270 | LOC105376287 | LOC105376326 | LOC105376344 | LOC105376356 | LOC105376360 | LOC105376361 | LOC105376372 | LOC105376375 | LOC105376387 | LOC105376391 | LOC105376397 | LOC105376400 | LOC105376407 | LOC105376412 | LOC105376413 | LOC105376422 | LOC105376435 | LOC105376440 | LOC105376442 | LOC105376481 | LOC105376482 | LOC105376483 | LOC105376486 | LOC105376502 | LOC105376504 | LOC105376505 | LOC105376512 | LOC105376523 | LOC105376536 | LOC105376548 | LOC105376558 | LOC105376559 | LOC105376566 | LOC105376576 | LOC105376579 | LOC105376583 | LOC105376595 | LOC105376611 | LOC105376622 | LOC105376626 | LOC105376627 | LOC105376645 | LOC105376659 | LOC105376707 | LOC105376732 | LOC105376740 | LOC105376755 | LOC105376767 | LOC105376781 | LOC105376786 | LOC105376805 | LOC105376809 | LOC105376815 | LOC105376817 | LOC105376818 | LOC105376819 | LOC105376823 | LOC105376845 | LOC105376850 | LOC105376885 | LOC105376898 | LOC105376934 | LOC105376981 | LOC105376991 | LOC105377013 | LOC105377016 | LOC105377022 | LOC105377043 | LOC105377046 | LOC105377054 | LOC105377056 | LOC105377095 | LOC105377097 | LOC105377102 | LOC105377103 | LOC105377134